HIV trials in China

In China 28 Also abroad 794

16 of 28 trials · From ClinicalTrials.gov, checked 13 November 2026. Ask the study team whether a trial fits you.

Phase 4Taking people
Immunogenicity and Safety of Freeze-Dried Human Rabies Vaccine (Vero Cell) in Patients Infected With Human Immunodeficiency Virus (HIV)
Where
Nanning
Age
18 years to 60 years
People
160
Run by
Liaoning Chengda Biotechnology CO., LTD
See details and how to joinNCT07932132
Phase 2Taking people
Targeted Therapies for Immunological Non-Responders in People With HIV: A Multicenter Clinical Study
Where
Beijing, Guangzhou, Shenzhen
Age
18 years to 60 years
People
21
Run by
Beijing 302 Hospital
See details and how to joinNCT07637877
Phase 1/2Taking people
A Study to Evaluate JL18008 in Subject With HIV Immunological Non-Responders
Where
Beijing
Age
18 years to 65 years
People
30
Run by
Jecho Biopharmaceuticals Co., Ltd.
See details and how to joinNCT07579741
No phaseTaking people
Optimization of Antiretroviral Therapy in Patients With AIDS-Related Lymphoma
Where
Shanghai
Age
18 years and over
People
60
Run by
Shanghai Public Health Clinical Center
See details and how to joinNCT07727642
Phase 1/2Taking people
Efficacy and Safety of ACC017 Tablets Compared With Dolutegravir Sodium Tablets in Treatment-Naïve Adults With Human Immunodeficiency Virus Type 1 (HIV-1)
Where
Beijing
Age
18 years and over
People
660
Run by
Jiangsu Aidea Pharmaceutical Group Co., Ltd.
See details and how to joinNCT07711223
No phaseNot yet taking people in China
Fuyang Jiedu Granules Plus Antiretroviral Therapy for HIV Immune Non-Responders With Spleen-Kidney Yang Deficiency
Where
Beijing
Age
18 years to 60 years
People
240
Run by
Beijing University of Chinese Medicine
See details and how to joinNCT07698548
No phaseNot yet taking people in China
Qiling Yiqi Tablets Plus Antiretroviral Therapy for HIV Immune Non-responders With Lung-Spleen Qi Deficiency
Where
Beijing
Age
18 years to 60 years
People
240
Run by
Beijing University of Chinese Medicine
See details and how to joinNCT07698574
Phase 1/2Not yet taking people in China
Efficacy and Safety of Immune Checkpoint Inhibitors for Refractory Opportunistic Infections in AIDS
Where
Shanghai
Age
18 years and over
People
50
Run by
Shanghai Public Health Clinical Center
See details and how to joinNCT07579247
Phase 1/2Taking people
Exploratory Study of LP-98 for Injection in ART-Naive HIV-Infected Individuals
Where
Tianjin
Age
18 years to 65 years
People
30
Run by
Shanxi Kangbao Biological Product Co., Ltd.
See details and how to joinNCT07433387
Phase 1/2Not yet taking people in China
A Safety and Efficacy Trial of Chidamide Combined With NKG2D CAR-NK Cell Therapy for Reducing the HIV Viral Reservoir
Where
Hangzhou
Age
18 years to 65 years
People
20
Run by
First Affiliated Hospital of Zhejiang University
See details and how to joinNCT07577986
Phase 1Taking people
The Efficacy and Safety Study of CAR-T Cells for Functional Cure in HIV-1/AIDS Patients
Where
Tianjin
Age
18 years to 65 years
People
3
Run by
Institute of Hematology & Blood Diseases Hospital, China
See details and how to joinNCT06880380
No phaseTaking people
We-INtervention Among Chinese HIV-serodiscordant Male Couples
Where
Chengdu, Guangzhou, Shenzhen, Xiamen
Age
18 years and over
People
320
Run by
City University of Hong Kong
See details and how to joinNCT06639932
Phase 2Taking people
A Phase Ⅱa Clinical Study of CL-197 Capsules
Where
Beijing
Age
18 years to 60 years
People
24
Run by
Henan Genuine Biotech Co., Ltd.
See details and how to joinNCT07308782
Phase 1/2Taking people
Mesenchymal Stem Cells Treatment for AIDS Patients at Late Stage
Where
Beijing, Shenzhen, Shijiazhuang
Age
18 years to 65 years
People
150
Run by
Cell Energy Life Sciences Group Co. LTD
See details and how to joinNCT05939167
Phase 4Not yet taking people in China
Same-Day Restart of B/F/TAF in HIV Patients After NNRTI Discontinuation
Where
Chian
Age
18 years and over
People
250
Run by
National Center for AIDS/STD Control and Prevention, China CDC
See details and how to joinNCT06830668
Phase 1Taking people
The Effect of Chimeric Antigen Receptor (CAR)-T Cell Therapy on the Reconstitution of HIV-specific Immune Function
Where
Guangzhou
Age
18 years to 60 years
People
40
Run by
Guangzhou 8th People's Hospital
See details and how to joinNCT03240328